InflaRx IFRX is preparing to release its quarterly earnings on Wednesday, 2025-05-07. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect InflaRx to report an earnings per share (EPS) of $-0.17.
The market awaits InflaRx’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings Track Record
The company’s EPS beat by $0.19 in the last quarter, leading to a 1.59% increase in the share price on the following day.
Here’s a look at InflaRx’s past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.27 | -0.21 | -0.24 |
| EPS Actual | -0.09 | -0.33 | -0.26 | -0.18 |
| Price Change % | 2.0% | 3.0% | 3.0% | 0.0% |
Performance of InflaRx Shares
Shares of InflaRx were trading at $1.65 as of May 05. Over the last 52-week period, shares are up 34.17%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for InflaRx visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Add Comment